Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Sodium Methoxide → 7-Chloro-2-methoxy-5-phenyl-3H-1,4-benzodiazepine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Sodium Methoxide | HCID 10942334 | — |
| 반응물 | 7-chloro-2-di-(morpholino)phosphinyloxy-5-phenyl-3H-1,4-benzodiazepin | HCID 14907886 | — |
| 용매 | Methanol | HCID 887 | — |
| 생성물 | 7-Chloro-2-methoxy-5-phenyl-3H-1,4-benzodiazepine | HCID 624942 | — |
반응 단계
To a solution of 24.5 mg. (0.5 mmoles) of 7-chloro-2-di-(morpholino)phosphinyloxy-5-phenyl-3H-1,4-benzodiazepine in 5 ml. of methanol at room temperature was added 82 mg. (1.5 mmoles) of sodium methoxide. The mixture was left at room temperature overnight. Methanol was evaporated and the residue was slurried with ether. Insoluble salts were removed by filtration. The clear ether solution was evaporated. Crystallization of the residue from petroleum ether yielded a final product having a m.p. of 94°-97°.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US04739049 |
| 출처 데이터셋 | uspto-grants-1988_04 |
| ORD ID | ord-17f948a8d4fd4ffc89a4c301235b8fc8 |
| 출처 메모 | uspto-grants-1988_04 |